180 Wealth Advisors LLC Has $132,000 Stake in The Beauty Health Company (NASDAQ:SKIN)

180 Wealth Advisors LLC decreased its position in shares of The Beauty Health Company (NASDAQ:SKIN) by 17.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 83,085 shares of the company’s stock after selling 17,616 shares during the period. 180 Wealth Advisors LLC’s holdings in Beauty Health were worth $132,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Sanctuary Advisors LLC increased its holdings in shares of Beauty Health by 49.2% in the third quarter. Sanctuary Advisors LLC now owns 36,695 shares of the company’s stock valued at $52,000 after purchasing an additional 12,103 shares in the last quarter. Barclays PLC increased its holdings in shares of Beauty Health by 224.7% in the third quarter. Barclays PLC now owns 106,103 shares of the company’s stock valued at $153,000 after purchasing an additional 73,425 shares in the last quarter. Orion Portfolio Solutions LLC acquired a new stake in shares of Beauty Health in the third quarter valued at approximately $65,000. Jacobs Levy Equity Management Inc. increased its holdings in shares of Beauty Health by 1.1% in the third quarter. Jacobs Levy Equity Management Inc. now owns 2,499,652 shares of the company’s stock valued at $3,599,000 after purchasing an additional 27,665 shares in the last quarter. Finally, HighTower Advisors LLC acquired a new stake in shares of Beauty Health in the third quarter valued at approximately $121,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group raised their price target on shares of Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $2.55.

Beauty Health Price Performance

Shares of SKIN stock opened at $1.55 on Thursday. The Beauty Health Company has a 52-week low of $0.91 and a 52-week high of $5.17. The stock has a market cap of $192.39 million, a PE ratio of -3.69 and a beta of 0.81. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The firm’s 50 day moving average price is $1.57 and its two-hundred day moving average price is $1.61.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.